Document is current
Any future updates will be listed below
-
Authors
Brenner, David https://orcid.org/0000-0002-1535-3146
Baumgartner, Tobias
von Spiczak, Sarah
Lewerenz, Jan
Weis, Roger
Grimmer, Anja
Gaspirova, Petra
Wurster, Claudia D.
Kunz, Wolfram S.
Wagner, Jan
Minassian, Berge A.
Elger, Christian E.
Ludolph, Albert C.
Biskup, Saskia
Döcker, Dennis
-
Funding
Funding for this research was provided by:
B. Braun Foundation (BBST-D-18-00064)
National Institute of Neurological Disorders and Stroke of the NIH (P01 NS097197)
- License Information
-
More Information
Article History
Received: 12 May 2019
Accepted: 16 August 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: This is a case series with informed consent by the patients or their parents, respectively. A separate ethics approval has not been considered necessary by the ethics committee of the University of Ulm.
: All patients or parents, respectively, gave their consent for publication.
: B.A. Minassian holds patents for diagnostic testing of the following genes: <i>EPM2A, EPM2B, MECP2</i>, and <i>VMA21</i>; and has received license fee payments/royalty payments from patents for diagnostic testing of the following genes: <i>EPM2A, EPM2B, MECP2</i>, and <i>VMA21</i>.The other authors declare that they have no competing interests.
